Literature DB >> 26998857

Sustainable efficient way for opioid peptide LVV-h7 preparation from enzymatic proteolysis in a microfluidic-based reaction-extraction process with solvent recycling.

Adil Elagli1, Kalim Belhacene1, Pascal Dhulster2, Renato Froidevaux3.   

Abstract

LVV-h7 (LVVYPWTQFR) is a bioactive peptide that can be obtained from blood as waste of food industry, more precisely from hemoglobin hydrolysis by pepsin. This opioid peptide belongs to the hemorphins family and have strong physiological effects that bring its use in pharmaceutics and various therapeutic treatments attractive, in particular for substituting its costly chemically synthetized analogous. Hemoglobin hydrolysis by pepsin generates a huge variety of peptides among whose LVV-h7 can be purified by liquid-liquid extraction (LLE). Herein, selective preparation of this peptide is proposed by a microfluidic-based continuous reaction-separation process. Hemoglobin hydrolysis in microreactor was firstly coupled to LVV-h7 LLE in octan-1-ol and then coupled to LVV-h7 back LLE in acidic water. This continuous process allowed to prepare pure LVV-h7, as confirmed by liquid chromatography and mass spectrometry. The microfluidic circuit also allowed octan-1-ol recycling in a closed loop, making this method more sustainable than similar biphasic batch process.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioactive peptide; Enzymatic hydrolysis; Liquid–liquid extraction; Microfluidics; Solvent recycling

Mesh:

Substances:

Year:  2016        PMID: 26998857     DOI: 10.1016/j.jchromb.2016.03.006

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

Review 1.  Hemorphins-From Discovery to Functions and Pharmacology.

Authors:  Przemyslaw Mielczarek; Kinga Hartman; Anna Drabik; Hao-Yuan Hung; Eagle Yi-Kung Huang; Ewa Gibula-Tarlowska; Jolanta H Kotlinska; Jerzy Silberring
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.